Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Clinical trial NCT00321633 · COMPLETED

Trial details

NCT number: NCT00321633
Sponsor: University College London Hospitals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

brca1 Mutation Carrier brca2 Mutation Carrier Breast Cancer Hereditary Breast/Ovarian Cancer (brca1, brca2)

Start date: 2005-09-01
Primary completion: 2009-09-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.